Skip to content

09688.HK

Zai Lab Ltd.

HKSE · Healthcare · Biotechnology · CN

HKD 17.37
−1.75%
Ask drillr

Year over year

Reported trailing growth

Revenue
+5.0%
EBITDA
-5.4%
EBIT
-6.8%
EPS
+70.4%
Free cash flow
+41.7%
Operating cash flow
+27.4%

Forward estimates

Based on analyst estimates

Revenue
+7.5%
EBITDA
-3.7%
EPS
-23.5%

Three-year CAGR

Revenue
+28.9%
EBITDA
+11.6%
EBIT
+18.6%
Net income
+31.6%
EPS
+38.5%
Free cash flow
+42.4%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026